首页> 外国专利> PREDICTION FOR PATIENTS ADMITTED TO INTENSIVE CARE OF THE RISK OF DEVELOPING DISSEMINATED INFECTION

PREDICTION FOR PATIENTS ADMITTED TO INTENSIVE CARE OF THE RISK OF DEVELOPING DISSEMINATED INFECTION

机译:减轻重度感染的风险允许患者接受治疗的预测

摘要

A method for predicting the risk of developing a disseminated infection in a patient admitted to intensive care having no clinical symptoms of such infection includes: determining a first dose of gelsolin G1 in a biological sample from the patient originating from a first sample taken at time T1, carried out between the day of intensive care admission and 48 hours afterward; determining a second dose of gelsolin G2 in a biological sample from the patient originating from a second sample taken at time T2, carried out two to three days after the first sampling; calculating the variation between the dose of gelsolin G2 and the dose of gelsolin G1, giving a Δ value; and comparing the Δ value to a threshold value S determined beforehand from two patient populations admitted to intensive care, one not having developed a disseminated infection and the other having developed such an infection.
机译:一种在没有这种感染的临床症状的接受重症监护的患者中预测发生弥散性感染风险的方法,该方法包括:确定来自患者的生物样品中凝溶胶蛋白G1的第一剂量,该剂量来自于时间T1采集的第一份样品在重症监护室入院之日至48小时后进行;确定来自患者的生物样品中凝溶胶蛋白G2的第二剂量,该剂量来自在时间T2采集的第二次样品,该时间是在第一次采样后两到三天进行的;计算凝溶胶蛋白G2的剂量与凝溶胶蛋白G1的剂量之间的变化,给出Δ值;将Δ值与预先从两个接受重症监护的患者群体确定的阈值S进行比较,其中一个未发生弥散性感染,另一个未发生这种感染。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号